Metric Finance
LearnFAQ
LearnFAQ

Learn / CGC

NASDAQ: CGC

Canopy Growth (CGC) stock, explained like you're 5

Canopy Growth trades on the Nasdaq under the ticker CGC. It is a small cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 350 million dollars.

Ticker
CGC
Exchange
Nasdaq
Sector
Healthcare
Industry
Medicinal Chemicals and Botanical Products
Size
Small cap, about 350 million dollars

Is Canopy Growth a small, medium or large cap company?

No. Canopy Growth is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 350 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Canopy Growth makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves CGC stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth. (The Motley Fool)
  • Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market (Yahoo Finance)
  • TLRY Vs CGC Vs ACB: Which Cannabis Stock Gets The Biggest High If Regulatory Fog Clears? (Stocktwits)
  • Trump's Executive Order Impacts Marijuana Stocks (Intellectia AI)
  • After 30 business days below $1, Canopy Growth (Nasdaq: CGC) gets a compliance deadline. (Stock Titan)

Follow CGC in your daily brief

Each trading day at 5 PM ET we post what happened to Canopy Growth and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow CGC

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Canopy Growth stock

What does Canopy Growth do?

Canopy Growth trades on the Nasdaq under the ticker CGC. It is a small cap company in the medicinal chemicals and botanical products industry, part of the healthcare sector, with a market value of about 350 million dollars.

What is the ticker symbol for Canopy Growth?

Canopy Growth trades under the ticker CGC on the Nasdaq.

What is Canopy Growth's market cap?

Canopy Growth is a small cap stock with a market cap of about 350 million dollars.

How does Canopy Growth make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves CGC stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow CGC stock every day?

Add CGC to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow CGC daily

A free brief on Canopy Growth and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BTI · British American Tobacco p.l.c.
  • DFTX · Definium Therapeutics
  • RGC · Regencell Bioscience Holdings Ltd
  • RLX · RLX Technology

Similar stocks

  • BTIBritish American Tobacco p.l.c.
  • DFTXDefinium Therapeutics
  • RGCRegencell Bioscience Holdings Ltd
  • RLXRLX Technology

Compare CGC: CGC vs BTI, CGC vs DFTX, CGC vs RGC

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed